Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6041780 | Neuromuscular Disorders | 2012 | 4 Pages |
Abstract
Capecitabine plus oxaliplatin combination (XELOX) is the first-line treatment in metastatic colorectal cancer. Here we report a case of acute, severe but substantially reversible, neuromuscular and cardiac toxicity following XELOX chemotherapy. Muscle biopsy findings were consistent with a toxic myopathy with necrotizing features and vacuolar changes; COX-negative fibers were also present. The time course could support a main role for capecitabine, which may have some neurotoxic effects (more frequently central), but a detrimental interaction between the two drugs cannot be ruled out and further studies are needed.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Daniele Orsucci, Chiara Pizzanelli, Greta Alì, Rosanna Calabrese, Giulia Ricci, Paola Lenzi, Lucia Petrozzi, Policarpo Moretti, Gabriele Siciliano,